Welcome to the Oxy-17 LLC. Media Center, where you can review news, learn about upcoming events and access publications and abstracts related to our Oxy-17® technology platform.

For media inquiries, please contact:

Oxy-17 LLC News

RTL is a member of MTEC (Medical technology enterprise consortium) since January 2021 and has been invited to DOD funding and contract RFI’s for use to enhance oxygen delivery.

Conference link: "Oxy-17 LLC ", has been ACCEPTED to SHOWCASE its disruptive Nano-technology OxyFusion™ MRI medium at this year's TechConnect World Innovation Summit & Expo, co-located with the National Innovation Summit and National SBIR/STTR Conference, May 23-25, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD.

Rockland Technimed Ltd is a Theranostics company, committed to the early diagnosis and treatment of hypoxic injury. Rockland's disruptive Nano-technology OxyFusion™ MRI medium enriched with its patented Oxy-17® process may set the new Gold standard of Cellular metabolic imaging without radiotracers.


Hazards of Current Imaging Agent in Use:

Biohazard hazard Reports of Gadolinium: FDA Radiological Society of North America

Environmental hazard Reports of Gadolinium:

NIH Report American Chemical Society Stanford University Global Regulatory News

• U.S. Food and Drug Administration Information on Gadolinium-Based Contrast Agents • Health Canada Advises Canadians of Safety Issues Related to Gadolinium-Containing Contrast Agents Used in Magnetic Resonance Imaging (MRI) • UK Medicines and Healthcare products Regulatory Agency Drug Safety Update on Gadolinium-containing Contrast Agents: New Advice to Minimise the Risk of Nephrogenic Systemic Fibrosis • European Medicines Agency Makes Recommendations to Minimise Risk of Nephrogenic Systemic Fibrosis with Gadolinium-containing Contrast Agents

Publications and Abstracts Click on this link for Publications & Abstracts in PDF format

A word from our Founder